Intellect Neurosciences, Inc. Validates Pivotal European Patent ... - MarketWatch by Alzheimers treatment

Wed, 19 Nov 2008 01:38:54 -0500

Intellect Neurosciences, Inc. Validates Pivotal European Patent ... - MarketWatch

by Alzheimers treatment @ Wed, 19 Nov 2008 01:38:54 -0500

Intellect Neurosciences, Inc. Validates Pivotal European Patent ...
MarketWatch -Nov 11, 2008
a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease (AD), ...
Intellect Neurosciences, Inc. Validates Pivotal European Patent ...PR Newswire (press release)
all 15 news articles